Hybrid SPECT-CT greatly improves localization of gastrointestinal bleeding

May 8, 2014

Prompt and accurate localization of the site of bleeding is critical for the management of patients with acute GI bleeding. Planar 99mTc-labeled RBC scintigraphy is sensitive for detection of acute gastrointestinal (GI) bleeding but its accuracy for localization of a bleeding source is arguable, particularly in patients with complex GI anatomy from prior surgeries.

Researchers at the Cleveland Clinic reviewed cases of GI in patients who had a concurrent hybrid SPECT–CT for evaluating equivocal 99mTc-labeled RBC activity on planar . Of those whose GI bleeding (as opposed to abdominal RBC activity due to other causes) was confirmed, SPECT–CT was 100 percent accurate in identifying the location of the bleeding.

"Judicious utilization of hybrid SPECT–CT for localization of the site of GI bleeding has the potential to improve clinical care by eliminating the ambiguities of planar scintigraphy," said researcher Ajit Goenka. "Based on the performance of SPECT–CT in this study, we are [working] to make it a routine practice at our institution."

Explore further: Even low-dose aspirin may increase risk of GI bleeding

More information: Dr. Goenka and his colleagues will present the study on May 8 at the 2014 ARRS Annual Meeting in San Diego, CA.

Related Stories

Even low-dose aspirin may increase risk of GI bleeding

September 12, 2011

The risk of gastrointestinal (GI) bleeding needs to be considered when determining the potential preventive benefits associated with low-dose aspirin for cardiovascular disease and cancer. According to a new study in Clinical ...

Low rates of gastrointestinal bleeding post-lumbar fusion

September 4, 2013

(HealthDay)—The rates of gastrointestinal (GI) hemorrhage complications are very low following lumbar fusion surgery, but are associated with greater costs and mortality, according to a study published in the Aug. 15 issue ...

Recommended for you

Ebola virus mutations may help it evade drug treatment

September 11, 2015

Genetic mutations called "escape variants" in the deadly Ebola virus appear to block the ability of antibody-based treatments to ward off infection, according to a team of U.S. Army scientists and collaborators. Their findings, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.